Acyclovir
Product Images NDC 50090-3902

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Acyclovir (NDC 50090-3902). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Acy03 0000 01)

FDA Label Image

Table 1 (Acy03 0000 02)

Table 1 (Acy03 0000 02)
This is a table that shows the pharmacokinetic characteristics of Acyclovir. It includes information about the range of plasma protein binding and plasma elimination half-life as well as the average oral bioavailability, which decreases with increasing dose.*
FDA Label Image

Table 2 (Acy03 0000 03)

Table 2 (Acy03 0000 03)
This is a table showing the Acyclovir peak and trough concentrations at steady state for 200mg, 400mg, and 800mg dosages. The table also includes values for Coax and C_irough in meg/mL.*
FDA Label Image

Table 3 (Acy03 0000 04)

Table 3 (Acy03 0000 04)
This is a dosage modification table for patients with renal impairment. The table provides adjusted dosage regimens based on the patient's creatinine clearance (mL/min/1.73 m2), with corresponding dosages (in mg) and dosing interval recommendations. The normal dosage and adjusted dosages for various medications are presented in the table.*
FDA Label Image

Label Image (Lbl500903902)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.